Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details | India News
File photo: ANI NEW DELHI: The Centre has issued a detailed advisory on the use, risks and regulation…
BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025
BioXcel Therapeutics Company to host conference call at 8 a.m. ET, August 27, 2025 NEW HAVEN, Conn., Aug.…